SELECTION OF PATIENTS WITH CONCOMITANT CHRONIC OBSTRUCTIVE DISEASE FOR ANATOMICAL RESECTIONS IN LUNG CANCER (review of literature)

The analysis of literature on the possibility of performing anatomical pulmonary resections in patients with concomitant COPD was performed. According to most researchers, FEV1 and DL (CO) more than 80 % indicated a high probability of an uncomplicated postoperative period after any anatomical resection of the lung. If the specified parameters were less than 80 %, additional studies were required: functional tests (6-minute walk test, staircase test), stress testing, calculation of predicted postoperative values of respiratory function, and, if necessary, lung scintigraphy could be performed to study regional respiratory function. The decision about the possibility and need for surgical treatment should have been made individually at the threshold values of these parameters. At the same time, there is currently no system for assessing the risk of postoperative complications for a particular patient, based on all the information about it, which represents the potential for further research.

The authors declare no conflict of interest.

The authors confirm that they respect the rights of the people participated in the study, including obtaining informed consent when it is necessary, and the rules of treatment of animals when they are used in the study. Author Guidelines contains the detailed information.

1. Global Initiative for Chronic Obstructive Lung Desease. Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary desease / ed. by Rebecca Decker. Global Initiative for Chronic Obstructive Lung Desease, Inc. 2018.

2. Gatti G., Gardu G., Lusa A. M. et al. Predictors of postoperative complications in high-risk octogenarians undergoing cardiac operations. Ann Thoracic surgery. 2002;(74):671–677.

3. Fisher B. W., Majumdar S. R., McAlister F. A. Predicting pulmonary complications after nonthoracic surgery a systematic review of blinded studies. Am J Med. 2002;(112):219–225.

4. Aokage K., Yoshida J., Hishida T. Limited resection for early-stage nonsmall cell lung cancer as function-preserving radical surgery: a review. Jpn J Clin Oncol. 2017 Jan;47(1):7–11.

5. Yaitskii N. A., Varlamov V. V., Gorbunkov S. D. Rezul’taty khirurgicheskogo lecheniya generalizovannoi emfizemy legkikh. Vestnik khirurgii im. I. I. Grekova. 2014;173(2):9–13. (In Russ.).

6. Myasnikova M. N. Emfizema legkikh. Khirurgicheskie aspekty. Petrozavodsk, Petrozavodskij gosudarstvennyj universitet im. O. V. Kuusinena. 1975. (In Russ.).

7. Nakagawa M., Tanaka H., Tsukuma H. et al. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 2001;120(3):705–710.

8. Barrera R., Shi W., Amar D. et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest. 2005;127(6):1977–1983.

9. Groote-Bidlingmaier von F. Functional evaluation before lung resection. Clin Chest Med. 2011;(32):773–782.

10. Mazzone P. J. Evaluation of the lung cancer resection candidate. Expert Review Respir Med. 2010 Feb;4(1):97–113 .

11. Akopov A. L., Chernyj S. M. Khirurgicheskoe lechenie raka legkogo u pozhilykh bol’nykh. Vestnik khirurgii im. I. I. Grekova. 2005;164(3):112– 115. (In Russ.).

12. Armstrong P., Congleton J., Fountain S. W. et al. Guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;(56):89–108.

13. Gaensler E. A. The role of pulmonary insuffiency in mortality and invalidism folloving surgery for pulmonary tuberculosis. J Thorac Cardiovasc Surg. 1995;29(163):337.

14. Burke J. R., Duarte I. G., Miller J. I. et al. Preoperative risk assessment for marginal patients requiring pulmonary resection. Ann Thoracic Surg. 2003;76(5):1767–1773.

15. Datta D., Lahiri B. Preoparative evalution of patients undergoing lung resection surgery. Chest. 2003;123(6):250–260.

16. Mountain C. F., McMurtrey M. T., Frazier O. H. Extending resectability for carcinoma of the lung in patients with impaired pulmonary function. Ann Thorac surg. 1978;26(3):250–260.

17. Boushy S. F., Billig D. M., North L. B. et al. Clinical сourse related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971;59(4):383–391.

18. Mittman C. Assesment of operative risk in thoracic surgery. Am Rev Respir Dis. 1961;(84):197–207.

19. Nagasaki F., Flehinger B. J., Martini N. Complications of Surgery in the treatment of carcinoma of the lung. Chest. 1982;82(1):25–29.

20. Pate P., Tenholder M. F., Griffin J. P. et al. Preoperative assessment of the high risk patients for lung resection. Ann Thorac Surg. 1996;61(5): 1494–1500.

21. Markos J., Mullan B. P., Hillman D. R. et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139(4):902–910.

22. Wahi R., McMurtey M. J., DeCaro L. F. et al. Determinations of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg. 1989;48(1):33–37.

23. Bolliger C. T., Wyser C., Roser H. et al. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest. 1995;108(2):341–348.

24. Nakahara K., Ohno K., Hashimoto J. et al. Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer. Ann Thorac Surg. 1988;46(5):549–552.

25. Yablonskii P. K., Petrun’kin A. M., Nikolaev G. V. Izmenenie funktsional’noi sposobnosti legkikh posle lobektomii u bol’nykh s soputstvuyushchei khronicheskoi obstruktivnoi bolezn’yu legkikh. Vestnik khirurgii im. I. I. Grekova. 2009;168(3):26–30. (In Russ.).

26. Kashiwabara K., Sasaki J., Mori T. et al. Relationship Between Functional Preservation after Segmentectomy and Volume-Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients with Emphysema. Journal of thoracic oncology. 2009;4(9):1111–1116.

27. Ferguson M. K., Lehman A. G., Bolliger C. T. et al. The role of diffusing capacity and exercise tests. Thorac Surg Clin. 2008;18(1):9–17.

28. Cander L. Physiologic assessment and management of the preoperative patient with pulmonary emphysema. Am J Cardiol. 1963;(12):324–326.

29. Ferguson M. K., Little L., Rizzo L. et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988;96(6):894–900.

30. Markos J., Mullan B. P., Hillman D. R. et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Respir Dis. 1989;139(4):902–910.

31. Ferguson M K., Reeder L. B., Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995;109(2):275–281.

32. Berrisford R., Brunelli A., Rocco G. et al. The European Thoracic Surgery Database project modelingthe risk of in-hospital death following lung resection. Eur J Cardiothoracic Surg. 2005;28(2):306–311.

33. Valera G., Brunelli A., Rocco G. Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy. Eur J Cardiothorac Surg. 2006;30(4):644–648.

34. Brunelli A., Refai M., Xiume F. Oxigen desaturation during maximal stairclimbing test and postoperative test after major lung resections. Eur J Cardiothorac Surg. 2008;33(1):77–82.

35. Brunelli A. Algorithm for functional evaluation of lung resection candidates: time for reappraisal? Respiration. 2009;78(1):117–118.

36. Herdy A. H., Ritt L. E. F., Stein R. Cardiopulmonary Exercise Test: Background, Applicability and Interpretation. Arq Bras Cardiol. 2016;107(5): 467–548.

37. Kubori Y., Matsuki R., Hotta A. Association between Pulmonary Function and Stair-Climbing Test Results after Lung Resection: A Pilot Study. Can Respir J. 2018 Sep 9;2018:1925028.

38. Messaggi-Sartor M., Marco E., Martínez-Téllez E. Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial. Eur J Phys Rehabil Med. 2019;55(1):113–122. Doi: 10.23736/S1973- 9087.18.05156-0.

39. Kallianos A., Rapti A., Tsimpoukis S. Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection. In Vivo. 2014 Nov-Dec;28(6):1013–1020.

40. Sawabata N., Nagayasu T., Kadota Y. Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014. Gen Thorac Cardiovasc Surg. 2015 Jan;63(1):14–21.

41. Weisman I. M. Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery. Semin Thorac Cardiovasc Surg. 2001 Apr;13(2):116–125.

42. Brunelli A., Belardinelli R., Refai M. Peak oxigen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest. 2009 May;135(5):1260–1267.

43. Salati M., Brunelli A. Risk Stratification in Lung Resection. Curr Surg Rep. 2016;4(11):37.

44. Holvoet Т., Meerbeeck J. P. van, Wiele C. van de. Quantitative Perfusion Scintigraphy or Anatomic Segment Method in lung cancer resection. Lung Cancer. 2011 Nov;74(2):212–218.

45. Ueda K., Murakami J., Sano F. Similar radiopathological features, but different postoperative recurrence rates, between Stage I lung cancers arising in emphysematous lungs and those arising in nonemphysematous lungs. Eur J Cardiothorac Surg. 2015 May;47(5):905–911.

46. Thoracoscore / SFAR.org. Available at: https://sfar.org/scores2/thoracoscore2.php#haut (accessed: 30.10.2018).

47. Bolliger C. T. Functional reserve before lung resection: how low can we go? Respiration. 2009;78(1):20–22.

48. Mineo T. C., Schillaci O., Pompeo E. Usefulness of Lung Perfusion Scintigraphy Before Lung Cancer Resection in Patients with Ventilatory Obstruction. The Annals of Thoracic Surgery. 2006 Nov;82(5): 1828–1834.

49. Win T., Tasker A. D., Groves A. M. Ventilation-Perfusion Scintigraphy to Predict Postoperative Pulmonary Function in Lung Cancer Patients Undergoing Pneumonectomy. American Journal of Roentgenology. 2006 Nov;187(5):1260–1265.